233 related articles for article (PubMed ID: 30909389)
21. Clinical outcome of henipavirus infection in hamsters is determined by the route and dose of infection.
Rockx B; Brining D; Kramer J; Callison J; Ebihara H; Mansfield K; Feldmann H
J Virol; 2011 Aug; 85(15):7658-71. PubMed ID: 21593160
[TBL] [Abstract][Full Text] [Related]
22. Foodborne transmission of nipah virus in Syrian hamsters.
de Wit E; Prescott J; Falzarano D; Bushmaker T; Scott D; Feldmann H; Munster VJ
PLoS Pathog; 2014 Mar; 10(3):e1004001. PubMed ID: 24626480
[TBL] [Abstract][Full Text] [Related]
23. Lethal Nipah virus infection induces rapid overexpression of CXCL10.
Mathieu C; Guillaume V; Sabine A; Ong KC; Wong KT; Legras-Lachuer C; Horvat B
PLoS One; 2012; 7(2):e32157. PubMed ID: 22393386
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of a Single-Dose Nucleoside-Modified Messenger RNA Vaccine Encoding Hendra Virus-Soluble Glycoprotein Against Lethal Nipah virus Challenge in Syrian Hamsters.
Lo MK; Spengler JR; Welch SR; Harmon JR; Coleman-McCray JD; Scholte FEM; Shrivastava-Ranjan P; Montgomery JM; Nichol ST; Weissman D; Spiropoulou CF
J Infect Dis; 2020 May; 221(Suppl 4):S493-S498. PubMed ID: 31751453
[TBL] [Abstract][Full Text] [Related]
25. Syrian Golden Hamster Model for Nipah Virus Infection.
Juelich T; Smith J; Freiberg AN
Methods Mol Biol; 2023; 2682():219-229. PubMed ID: 37610585
[TBL] [Abstract][Full Text] [Related]
26. A single-dose ChAdOx1-vectored vaccine provides complete protection against Nipah Bangladesh and Malaysia in Syrian golden hamsters.
van Doremalen N; Lambe T; Sebastian S; Bushmaker T; Fischer R; Feldmann F; Haddock E; Letko M; Avanzato VA; Rissanen I; LaCasse R; Scott D; Bowden TA; Gilbert S; Munster V
PLoS Negl Trop Dis; 2019 Jun; 13(6):e0007462. PubMed ID: 31170144
[TBL] [Abstract][Full Text] [Related]
27. A Recombinant Chimeric Cedar Virus-Based Surrogate Neutralization Assay Platform for Pathogenic Henipaviruses.
Amaya M; Yin R; Yan L; Borisevich V; Adhikari BN; Bennett A; Malagon F; Cer RZ; Bishop-Lilly KA; Dimitrov AS; Cross RW; Geisbert TW; Broder CC
Viruses; 2023 Apr; 15(5):. PubMed ID: 37243163
[TBL] [Abstract][Full Text] [Related]
28. Single-dose replication-defective VSV-based Nipah virus vaccines provide protection from lethal challenge in Syrian hamsters.
Lo MK; Bird BH; Chattopadhyay A; Drew CP; Martin BE; Coleman JD; Rose JK; Nichol ST; Spiropoulou CF
Antiviral Res; 2014 Jan; 101():26-9. PubMed ID: 24184127
[TBL] [Abstract][Full Text] [Related]
29. Recombinant measles virus vaccine expressing the Nipah virus glycoprotein protects against lethal Nipah virus challenge.
Yoneda M; Georges-Courbot MC; Ikeda F; Ishii M; Nagata N; Jacquot F; Raoul H; Sato H; Kai C
PLoS One; 2013; 8(3):e58414. PubMed ID: 23516477
[TBL] [Abstract][Full Text] [Related]
30. Protection against henipaviruses in swine requires both, cell-mediated and humoral immune response.
Pickering BS; Hardham JM; Smith G; Weingartl ET; Dominowski PJ; Foss DL; Mwangi D; Broder CC; Roth JA; Weingartl HM
Vaccine; 2016 Sep; 34(40):4777-86. PubMed ID: 27544586
[TBL] [Abstract][Full Text] [Related]
31. Genomic characterization, transcriptome analysis, and pathogenicity of the Nipah virus (Indian isolate).
Mohandas S; Shete A; Sarkale P; Kumar A; Mote C; Yadav P
Virulence; 2023 Dec; 14(1):2224642. PubMed ID: 37312405
[TBL] [Abstract][Full Text] [Related]
32. Nipah Virus Efficiently Replicates in Human Smooth Muscle Cells without Cytopathic Effect.
DeBuysscher BL; Scott DP; Rosenke R; Wahl V; Feldmann H; Prescott J
Cells; 2021 May; 10(6):. PubMed ID: 34070626
[TBL] [Abstract][Full Text] [Related]
33. Novel innate immune functions for galectin-1: galectin-1 inhibits cell fusion by Nipah virus envelope glycoproteins and augments dendritic cell secretion of proinflammatory cytokines.
Levroney EL; Aguilar HC; Fulcher JA; Kohatsu L; Pace KE; Pang M; Gurney KB; Baum LG; Lee B
J Immunol; 2005 Jul; 175(1):413-20. PubMed ID: 15972675
[TBL] [Abstract][Full Text] [Related]
34. Rescue and characterization of recombinant cedar virus, a non-pathogenic Henipavirus species.
Laing ED; Amaya M; Navaratnarajah CK; Feng YR; Cattaneo R; Wang LF; Broder CC
Virol J; 2018 Mar; 15(1):56. PubMed ID: 29587789
[TBL] [Abstract][Full Text] [Related]
35. Heparan sulfate-dependent enhancement of henipavirus infection.
Mathieu C; Dhondt KP; Châlons M; Mély S; Raoul H; Negre D; Cosset FL; Gerlier D; Vivès RR; Horvat B
mBio; 2015 Mar; 6(2):e02427. PubMed ID: 25759505
[TBL] [Abstract][Full Text] [Related]
36. Envelope-receptor interactions in Nipah virus pathobiology.
Lee B
Ann N Y Acad Sci; 2007 Apr; 1102(1):51-65. PubMed ID: 17470911
[TBL] [Abstract][Full Text] [Related]
37. Alterations in Blood Chemistry Levels Associated With Nipah Virus Disease in the Syrian Hamster Model.
Genzer SC; Welch SR; Scholte FEM; Harmon JR; Coleman-McCray JD; Lo MK; Montgomery JM; Nichol ST; Spiropoulou CF; Spengler JR
J Infect Dis; 2020 May; 221(Suppl 4):S454-S459. PubMed ID: 31747016
[TBL] [Abstract][Full Text] [Related]
38. A human lung xenograft mouse model of Nipah virus infection.
Valbuena G; Halliday H; Borisevich V; Goez Y; Rockx B
PLoS Pathog; 2014 Apr; 10(4):e1004063. PubMed ID: 24699832
[TBL] [Abstract][Full Text] [Related]
39. Organ- and endotheliotropism of Nipah virus infections in vivo and in vitro.
Maisner A; Neufeld J; Weingartl H
Thromb Haemost; 2009 Dec; 102(6):1014-23. PubMed ID: 19967130
[TBL] [Abstract][Full Text] [Related]
40. The immunomodulating V and W proteins of Nipah virus determine disease course.
Satterfield BA; Cross RW; Fenton KA; Agans KN; Basler CF; Geisbert TW; Mire CE
Nat Commun; 2015 Jun; 6():7483. PubMed ID: 26105519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
